Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose as Add-on Therapy in Bipolar Depression
NCT02800161Phase 3Completed
- Sponsor
- CiberMed
- Start
- Jun 2016
- Primary completion
- Oct 2022
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of trehalose in bipolar disorder (BD), sponsored by CiberMed. Started Jun 2016; status: completed.
02
Drugs
trehalose
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02800161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800161.